ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV‑2) causing coronavirus disease 2019 (COVID-19) has reached pandemic levels; Patients with cardiovascular (CV) risk factors and established cardiovascular disease (CVD) represent a vulnerable population when suffering from COVID-19; Patients with cardiac injury in the context of COVID-19 have an increased risk of morbidity and mortality